Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: JACC Heart Fail. 2019 Sep;7(9):771–778. doi: 10.1016/j.jchf.2019.06.010

Central Illustration: Cardiovascular Outcomes Associated with Carvedilol in HF patients with Cocaine Use Disorder (CUD).

Central Illustration:

In this study, HFrEF patients with CUD who were prescribed carvedilol had lower incidence of MACE (CV mortality and 30-day HF readmission), compared to those not prescribed carvedilol. No significant differences were seen in the HFmrEF and HFpEF cohorts.